Skip to Main Content

Paper Details

serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
OncoImmunology
4
2022
NSCLC, Pos, advanced melanoma, cancer, melanoma, patients
Author NameAffiliation
Ian R WatsonRosalind and Morris Goodman Cancer Institute
  • 1 - 1

Datasets

Release 1.2